Literature DB >> 18264917

[Nephrolithiasis in patients with intestinal diseases].

M Cirillo1, M Iudici, F Marcarelli, M Laudato, F Zincone.   

Abstract

Intestinal diseases may cause the formation of urinary stones through changes in the metabolism of oxalate, calcium, and uric acid. The oxalate that is excreted into urine comes from the catabolism of ascorbic acid and some amino acids or from intestinal absorption of food oxalate. Calcium is absorbed by the gut after the stimulation of active vitamin D and is excreted by the kidney under the control of the bone/parathyroid hormone axis. Uric acid is generated by the oxidation of exogenous and endogenous purine bases, is excreted by the kidney through glomerular filtration/tubular secretion, and is soluble in alkaline urine. Several data indicate that patients with inflammatory bowel diseases are at high risk of urinary stones containing calcium-oxalate salt or uric acid. Calcium-oxalate stones are caused by colonic oxalate hyperabsorption (secondary to intestinal dysfunction) or by parenteral nutrition. Uric acid stones are typical of patients with severe diarrhea and/or intestinal neostomy, that is, in patients with hyperconcentrated acidic urine. Relationships between malabsorptive intestinal diseases and urinary stones are less well defined. Preventive countermeasures are not the same for all disorders. Hyperoxaluria should be controlled by diets with a low content of lipids and oxalate but supplemented with calcium and probiotics. The presence of hyperconcentrated acidic urine should be controlled by correct hydration and administration of citrate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264917

Source DB:  PubMed          Journal:  G Ital Nefrol        ISSN: 0393-5590


  5 in total

1.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

2.  Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition.

Authors:  Fabio C Torricelli; Chad Reichard; Manoj Monga
Journal:  Int Urol Nephrol       Date:  2020-09-11       Impact factor: 2.370

3.  Nephrolithiasis in patients with inflammatory bowel disease in the community.

Authors:  Dídia Bismara Cury; Alan C Moss; Nestor Schor
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-07-29

4.  Urolithiasis and crohn's disease.

Authors:  Sandro Roberto da Silva Gaspar; Tiago Mendonça; Pedro Oliveira; Tiago Oliveira; José Dias; Tomé Lopes
Journal:  Urol Ann       Date:  2016 Jul-Sep

Review 5.  Is There Such a Thing as "Anti-Nutrients"? A Narrative Review of Perceived Problematic Plant Compounds.

Authors:  Weston Petroski; Deanna M Minich
Journal:  Nutrients       Date:  2020-09-24       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.